The focus of Enzymicals is to provide integrated solutions for biocatalytic applications. Dedicated to design, develop and implement cost-effective, sustainable and scalable chemo-biocatalytic routes. Enzymicals offers a recognized expertise in the application of enzymatic processes for the synthesis of complex chemicals up to industrial scale.
Dr. Rainer Wardenga will supervise ESR2. The former CSO of Enzymicals, He, steps down from the managing board due to a longer term parental leave.
Dr. Wardenga received his PhD at the Institute of Biochemistry, Dept. of Biotechnology & Enzyme Catalysis, University of Greifswald, Germany.